(Q36043819)

11 August 2017

Single versus multiple human-equivalent doses of C. parvum in mice: neutralization of the anti-metastatic effect (English)

1 reference

11 August 2017

Mitcheson HD

1

1 reference

11 August 2017

Sadler TE

series ordinal

2

1 reference

11 August 2017

Castro JE

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 March 1980

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

41

1 reference

11 August 2017

3

1 reference

11 August 2017

407-414

1 reference

Inhibitory effect of injection of Corynebacterium parvum on the growth of tumour transplants in isogenic hosts

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Corynebacterium parvum as an immunotherapeutic anticancer agent

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Intravascular coagulation resulting from intravenous injection of C. parvum in mice

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Factors interfering with immunological rejection of tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Clinical studies with Corynebacterium parvum

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Antitumor Activity of Corynebacterium Parvum

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Pharmacologic factors and manipulation of immunity systemic adjuvants in cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Accurate identification of experimental pulmonary metastases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

The effects of Corynebacterium parvum and surgery on the Lewis lung carcinoma and its metastases

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Effects of Corynebacterium granulosum on weight and histology of lymphoid organs, response to mitogens, skin allografts, and a syngeneic fibrosarcoma in mice

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Coagulation and fibrinolysis during the infusion of Corynebacterium parvum in man

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Effect of (plus or minus)-1,2-bis(3,5-dioxopiperazin-1-yl)propane on tumor blood vessels and its relationship to the antimetastatic effect in the Lewis lung carcinoma

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2010249

Inhibition of Tumour Growth by Administration of Killed Corynebacterium parvum

23 September 2018

1 reference

12 December 2020

Lympho-Reticular Stimulatory Properties of Corynebacterium Parvum and Related Bacteria

1 reference

12 December 2020

Increased incidence of lung metastases following treatment of rats bearing hepatomas with irradiated tumour cells and the benefical effect of Corynebacterium parvum in this system

1 reference

12 December 2020

Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection

1 reference

12 December 2020

Inhibitory effect of prolongedcorynebacterium parvum and cyclophosphamide administration on the growth of established tumors

1 reference

12 December 2020

A comparative study of anaerobic Coryneforms. Attempts to correlate their anti-tumour activity with their serological properties and ability to stimulate the lymphoreticular system

1 reference

12 December 2020

Daily intravenous infusions of Corynebacterium parvum in twenty patients with disseminated cancer: a preliminary report of clinical and biologic findings

1 reference

12 December 2020

The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice

1 reference

12 December 2020

Effects of BCG and Corynebacterium parvum on immune reactivity in melanoma patients

1 reference

12 December 2020

Studies in a tumor spectrum. III. The effect of phosphoramides on the growth of a variety of mouse and rat tumors

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1980.64

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

7387830

1 reference